CVS Health Corporation (0HRS.L)
USD 67.0
(9.62%)
USD 67.0
(9.62%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 74.67 Billion USD | 10.99% |
| 2022 | 67.27 Billion USD | -4.09% |
| 2021 | 70.14 Billion USD | -10.03% |
| 2020 | 77.96 Billion USD | -6.77% |
| 2019 | 83.62 Billion USD | 17.05% |
| 2018 | 71.44 Billion USD | 222.1% |
| 2017 | 22.18 Billion USD | -13.41% |
| 2016 | 25.61 Billion USD | -2.48% |
| 2015 | 26.26 Billion USD | 124.6% |
| 2014 | 11.69 Billion USD | -8.92% |
| 2013 | 12.84 Billion USD | 40.6% |
| 2012 | 9.13 Billion USD | -0.81% |
| 2011 | 9.2 Billion USD | 6.43% |
| 2010 | 8.65 Billion USD | -1.19% |
| 2009 | 8.75 Billion USD | 8.67% |
| 2008 | 8.05 Billion USD | -3.5% |
| 2007 | 8.34 Billion USD | 190.89% |
| 2006 | 2.87 Billion USD | 80.06% |
| 2005 | 1.59 Billion USD | -17.23% |
| 2004 | 1.92 Billion USD | 155.73% |
| 2003 | 753.1 Million USD | -30.03% |
| 2002 | 1.07 Billion USD | 32.81% |
| 2001 | 810.4 Million USD | 50.97% |
| 2000 | 536.8 Million USD | -3.89% |
| 1999 | 558.5 Million USD | 102.58% |
| 1998 | 275.7 Million USD | 1.14% |
| 1997 | 272.6 Million USD | -10.24% |
| 1996 | 303.7 Million USD | -7.32% |
| 1995 | 327.7 Million USD | -1.09% |
| 1994 | 331.3 Million USD | -3.07% |
| 1993 | 341.8 Million USD | -14.1% |
| 1992 | 397.9 Million USD | -4.88% |
| 1991 | 418.3 Million USD | -2.27% |
| 1990 | 428 Million USD | 9.8% |
| 1989 | 389.8 Million USD | 708.71% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 73.43 Billion USD | -1.61% |
| 2024 Q2 | 62.64 Billion USD | 8.58% |
| 2023 Q4 | 74.67 Billion USD | -2.03% |
| 2023 FY | 74.67 Billion USD | 10.99% |
| 2023 Q1 | 73.02 Billion USD | 8.54% |
| 2023 Q2 | 78.02 Billion USD | 6.86% |
| 2023 Q3 | 76.22 Billion USD | -2.31% |
| 2022 Q1 | 69.84 Billion USD | -0.43% |
| 2022 Q2 | 68.29 Billion USD | -2.22% |
| 2022 Q3 | 68.02 Billion USD | -0.41% |
| 2022 Q4 | 67.27 Billion USD | -1.1% |
| 2022 FY | 67.27 Billion USD | -4.09% |
| 2021 Q3 | 75.28 Billion USD | -3.23% |
| 2021 Q4 | 70.14 Billion USD | -6.83% |
| 2021 FY | 70.14 Billion USD | -10.03% |
| 2021 Q1 | 77.85 Billion USD | -0.14% |
| 2021 Q2 | 77.8 Billion USD | -0.07% |
| 2020 Q3 | 80.04 Billion USD | -2.5% |
| 2020 FY | 77.96 Billion USD | -6.77% |
| 2020 Q1 | 84.47 Billion USD | 1.02% |
| 2020 Q2 | 82.09 Billion USD | -2.82% |
| 2020 Q4 | 77.96 Billion USD | -2.59% |
| 2019 Q1 | 86.84 Billion USD | 21.56% |
| 2019 Q3 | 83.03 Billion USD | -3.21% |
| 2019 Q2 | 85.79 Billion USD | -1.22% |
| 2019 Q4 | 83.62 Billion USD | 0.71% |
| 2019 FY | 83.62 Billion USD | 17.05% |
| 2018 FY | 71.44 Billion USD | 222.1% |
| 2018 Q4 | 71.44 Billion USD | 17.61% |
| 2018 Q3 | 60.74 Billion USD | -1.34% |
| 2018 Q2 | 61.56 Billion USD | 0.03% |
| 2018 Q1 | 61.55 Billion USD | 177.5% |
| 2017 Q4 | 22.18 Billion USD | -5.15% |
| 2017 FY | 22.18 Billion USD | -13.41% |
| 2017 Q3 | 23.38 Billion USD | -8.73% |
| 2017 Q2 | 25.62 Billion USD | 0.0% |
| 2017 Q1 | 25.62 Billion USD | 0.03% |
| 2016 Q2 | 25.6 Billion USD | -2.54% |
| 2016 Q1 | 26.26 Billion USD | 0.0% |
| 2016 FY | 25.61 Billion USD | -2.48% |
| 2016 Q3 | 25.61 Billion USD | 0.04% |
| 2016 Q4 | 25.61 Billion USD | 0.02% |
| 2015 Q1 | 11.68 Billion USD | -0.05% |
| 2015 FY | 26.26 Billion USD | 124.6% |
| 2015 Q4 | 26.26 Billion USD | -1.88% |
| 2015 Q3 | 26.77 Billion USD | 130.13% |
| 2015 Q2 | 11.63 Billion USD | -0.48% |
| 2014 Q1 | 12.84 Billion USD | 0.03% |
| 2014 Q3 | 11.7 Billion USD | -4.43% |
| 2014 Q4 | 11.69 Billion USD | -0.12% |
| 2014 FY | 11.69 Billion USD | -8.92% |
| 2014 Q2 | 12.25 Billion USD | -4.62% |
| 2013 Q1 | 9.35 Billion USD | 2.4% |
| 2013 FY | 12.84 Billion USD | 40.6% |
| 2013 Q4 | 12.84 Billion USD | 45.61% |
| 2013 Q3 | 8.81 Billion USD | -5.76% |
| 2013 Q2 | 9.35 Billion USD | 0.06% |
| 2012 Q1 | 9.2 Billion USD | -0.02% |
| 2012 FY | 9.13 Billion USD | -0.81% |
| 2012 Q4 | 9.13 Billion USD | -0.84% |
| 2012 Q3 | 9.21 Billion USD | 0.02% |
| 2012 Q2 | 9.2 Billion USD | 0.02% |
| 2011 Q2 | 10.16 Billion USD | 17.29% |
| 2011 FY | 9.2 Billion USD | 6.43% |
| 2011 Q3 | 10.16 Billion USD | -0.01% |
| 2011 Q4 | 9.2 Billion USD | -9.43% |
| 2011 Q1 | 8.66 Billion USD | 0.2% |
| 2010 Q1 | 8.45 Billion USD | -3.45% |
| 2010 FY | 8.65 Billion USD | -1.19% |
| 2010 Q4 | 8.65 Billion USD | -0.01% |
| 2010 Q3 | 8.65 Billion USD | -8.47% |
| 2010 Q2 | 9.45 Billion USD | 11.83% |
| 2009 Q1 | 9.05 Billion USD | 12.4% |
| 2009 Q3 | 8.75 Billion USD | 19.86% |
| 2009 Q4 | 8.75 Billion USD | -0.0% |
| 2009 Q2 | 7.3 Billion USD | -19.34% |
| 2009 FY | 8.75 Billion USD | 8.67% |
| 2008 Q3 | 8.04 Billion USD | -3.6% |
| 2008 FY | 8.05 Billion USD | -3.5% |
| 2008 Q1 | 8.34 Billion USD | -0.01% |
| 2008 Q2 | 8.34 Billion USD | -0.01% |
| 2008 Q4 | 8.05 Billion USD | 0.12% |
| 2007 Q4 | 8.34 Billion USD | -0.54% |
| 2007 Q3 | 8.39 Billion USD | -0.01% |
| 2007 Q1 | 2.89 Billion USD | 0.87% |
| 2007 FY | 8.34 Billion USD | 190.89% |
| 2007 Q2 | 8.39 Billion USD | 189.96% |
| 2006 FY | 2.87 Billion USD | 80.06% |
| 2006 Q2 | 1.78 Billion USD | 11.81% |
| 2006 Q1 | 1.59 Billion USD | -0.12% |
| 2006 Q3 | 3.27 Billion USD | 84.24% |
| 2006 Q4 | 2.87 Billion USD | -12.49% |
| 2005 Q3 | 1.62 Billion USD | -0.11% |
| 2005 Q4 | 1.59 Billion USD | -2.08% |
| 2005 Q1 | 1.63 Billion USD | -15.2% |
| 2005 FY | 1.59 Billion USD | -17.23% |
| 2005 Q2 | 1.62 Billion USD | -0.21% |
| 2004 Q1 | 752.8 Million USD | -0.04% |
| 2004 FY | 1.92 Billion USD | 155.73% |
| 2004 Q2 | 752.5 Million USD | -0.04% |
| 2004 Q3 | 1.95 Billion USD | 159.44% |
| 2004 Q4 | 1.92 Billion USD | -1.35% |
| 2003 FY | 753.1 Million USD | -30.03% |
| 2003 Q2 | 775.9 Million USD | -0.03% |
| 2003 Q3 | 775.6 Million USD | -0.04% |
| 2003 Q4 | 753.1 Million USD | -2.9% |
| 2003 Q1 | 776.1 Million USD | -27.89% |
| 2002 Q4 | 1.07 Billion USD | 33.25% |
| 2002 Q3 | 807.7 Million USD | -0.02% |
| 2002 Q2 | 807.9 Million USD | -0.28% |
| 2002 Q1 | 810.2 Million USD | -0.02% |
| 2002 FY | 1.07 Billion USD | 32.81% |
| 2001 Q3 | 836.2 Million USD | -0.02% |
| 2001 Q2 | 836.4 Million USD | -0.02% |
| 2001 Q1 | 836.6 Million USD | 55.85% |
| 2001 FY | 810.4 Million USD | 50.97% |
| 2001 Q4 | 810.4 Million USD | -3.09% |
| 2000 FY | 536.8 Million USD | -3.89% |
| 2000 Q2 | 558 Million USD | -0.04% |
| 2000 Q3 | 557.8 Million USD | -0.04% |
| 2000 Q4 | 536.8 Million USD | -3.76% |
| 2000 Q1 | 558.2 Million USD | -0.05% |
| 1999 Q1 | 575.5 Million USD | 108.74% |
| 1999 Q3 | 575.2 Million USD | -0.21% |
| 1999 Q4 | 558.5 Million USD | -2.9% |
| 1999 Q2 | 576.4 Million USD | 0.16% |
| 1999 FY | 558.5 Million USD | 102.58% |
| 1998 Q1 | 272.6 Million USD | 0.0% |
| 1998 Q3 | 288.2 Million USD | -0.07% |
| 1998 Q4 | 275.7 Million USD | -4.34% |
| 1998 FY | 275.7 Million USD | 1.14% |
| 1998 Q2 | 288.4 Million USD | 5.8% |
| 1997 Q1 | 294 Million USD | -3.19% |
| 1997 Q2 | 591.7 Million USD | 101.26% |
| 1997 FY | 272.6 Million USD | -10.24% |
| 1997 Q4 | 272.6 Million USD | -12.96% |
| 1997 Q3 | 313.2 Million USD | -47.07% |
| 1996 Q3 | 321.3 Million USD | -0.03% |
| 1996 FY | 303.7 Million USD | -7.32% |
| 1996 Q1 | 327.5 Million USD | -0.06% |
| 1996 Q2 | 321.4 Million USD | -1.86% |
| 1996 Q4 | 303.7 Million USD | -5.48% |
| 1995 FY | 327.7 Million USD | -1.09% |
| 1995 Q4 | 327.7 Million USD | -1.32% |
| 1995 Q3 | 332.1 Million USD | 0.27% |
| 1995 Q2 | 331.2 Million USD | -0.03% |
| 1995 Q1 | 331.3 Million USD | 0.0% |
| 1994 Q4 | 331.3 Million USD | -3.02% |
| 1994 Q3 | 341.6 Million USD | -0.03% |
| 1994 Q2 | 341.7 Million USD | 0.0% |
| 1994 Q1 | 341.7 Million USD | -0.03% |
| 1994 FY | 331.3 Million USD | -3.07% |
| 1993 FY | 341.8 Million USD | -14.1% |
| 1993 Q1 | 396.1 Million USD | -0.45% |
| 1993 Q2 | 399 Million USD | 0.73% |
| 1993 Q3 | 395.1 Million USD | -0.98% |
| 1993 Q4 | 341.8 Million USD | -13.49% |
| 1992 Q2 | 411.8 Million USD | -0.6% |
| 1992 FY | 397.9 Million USD | -4.88% |
| 1992 Q4 | 397.9 Million USD | -2.64% |
| 1992 Q1 | 414.3 Million USD | -0.96% |
| 1992 Q3 | 408.7 Million USD | -0.75% |
| 1991 FY | 418.3 Million USD | -2.27% |
| 1991 Q1 | 391 Million USD | -8.64% |
| 1991 Q4 | 418.3 Million USD | -0.69% |
| 1991 Q3 | 421.2 Million USD | -0.28% |
| 1991 Q2 | 422.4 Million USD | 8.03% |
| 1990 FY | 428 Million USD | 9.8% |
| 1990 Q1 | 396.5 Million USD | 1.72% |
| 1990 Q3 | 406.7 Million USD | 2.86% |
| 1990 Q4 | 428 Million USD | 5.24% |
| 1990 Q2 | 395.4 Million USD | -0.28% |
| 1989 FY | 389.8 Million USD | 708.71% |
| 1989 Q1 | 46.4 Million USD | -3.73% |
| 1989 Q2 | 402.8 Million USD | 768.1% |
| 1989 Q3 | 394.8 Million USD | -1.99% |
| 1989 Q4 | 389.8 Million USD | -1.27% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Phreesia, Inc. | 2.04 Million USD | -3644214.3% |
| Accuray Incorporated | 164.4 Million USD | -45320.925% |
| Align Technology, Inc. | 96.96 Million USD | -76906.848% |
| Elevance Health Inc. | 23.24 Billion USD | -221.225% |
| AxoGen, Inc. | 46.6 Million USD | -160130.028% |
| Boston Scientific Corporation | 8.56 Billion USD | -771.725% |
| Cardinal Health, Inc. | 4.58 Billion USD | -1529.326% |
| Centene Corporation | 17.69 Billion USD | -321.9% |
| DaVita Inc. | 8.05 Billion USD | -827.458% |
| HCA Healthcare, Inc. | 36.62 Billion USD | -103.866% |
| Hologic, Inc. | 2.49 Billion USD | -2890.349% |
| Humana Inc. | 10.21 Billion USD | -631.147% |
| IDEXX Laboratories, Inc. | 622.88 Million USD | -11888.126% |
| Laboratory Corporation of America Holdings | 4.05 Billion USD | -1741.616% |
| Masimo Corporation | 871.7 Million USD | -8466.25% |
| McKesson Corporation | 5.45 Billion USD | -1269.877% |
| Patterson Companies, Inc. | 328.91 Million USD | -22602.798% |
| Quest Diagnostics Incorporated | 4.41 Billion USD | -1593.243% |
| ResMed Inc. | 697.31 Million USD | -10608.534% |
| Henry Schein, Inc. | 1.93 Billion USD | -3763.011% |
| Teladoc Health, Inc. | 1.58 Billion USD | -4621.519% |
| Universal Health Services, Inc. | 4.71 Billion USD | -1483.329% |
| Veeva Systems Inc. | 46.44 Million USD | -160688.958% |
| Baxter International Inc. | 11.06 Billion USD | -574.91% |
| Becton, Dickinson and Company | 14.73 Billion USD | -406.663% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 91052.497% |
| Danaher Corporation | 17.66 Billion USD | -322.807% |
| Stryker Corporation | 10.9 Billion USD | -585.001% |
| Medtronic plc | 23.87 Billion USD | -212.736% |